Department of Neurology, Key Laboratory for Neurological Big Data of Liaoning Province, The First Affiliated Hospital of China Medical University, Shenyang, China; Department of Neurology, China-Japan Friendship Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Department of Neurology, Key Laboratory for Neurological Big Data of Liaoning Province, The First Affiliated Hospital of China Medical University, Shenyang, China.
Neurotoxicology. 2023 May;96:81-91. doi: 10.1016/j.neuro.2023.04.001. Epub 2023 Apr 3.
Microglia, which are the primary inflammatory cells of the brain, can undergo phenotypic switching between M1 and M2 polarization, which have opposing effects on inflammation. Peroxisome proliferator-activated receptor gamma (PPARγ) is a member of the nuclear receptor family of ligand-inducible transcription factors, and PPARγ is known to regulate M2 macrophage polarization. Previous studies have shown that the natural pentacyclic triterpenoid ursolic acid (3β-hydroxy-urs-12-en-28-oic acid; UA) influences microglial activation. Additionally, UA increases tissue inhibitor matrix metalloproteinase 1 (TIMP1), while greatly reducing the release of matrix metalloproteinase 2 (MMP2) and MMP9 in a PPARγ-dependent manner. Here, we examined the anti-inflammatory properties of UA by observing how well it promotes the phenotypic transition of lipopolysaccharide (LPS) and interferon gamma (IFNγ)-activated BV2 microglia from M1 to M2 polarization. To determine if PPARγ is involved in the underlying molecular pathway, we treated rats with UA and the PPARγ inhibitor BADGE. We also investigated the mechanisms by which PPARγ controls transcription from the MMP2 promoter. The in-vitro experiments showed that UA shifted LPS/IFNγ-activated BV2 microglia from the M1 to the M2 phenotype, which was associated with a reduction in the neurotoxic factors MMP2 and MMP9, and an increase in the anti-inflammatory factor TIMP1. Co-treatment with increased MMP2 and MMP9 synthesis while decreasing TIMP1 release, indicating that UA has anti-inflammatory effects on LPS/IFNγ-activated BV2 cells via activation of PPARγ. Next, we found that PPARγ directly influences MMP2 transcriptional activity by identifying the crucial peroxisome proliferator response element (PPRE) among five potential PPREs in the MMP2 promoter. These results suggest that UA has a protective anti-inflammatory effect against neuroinflammatory toxicity, which is exerted by direct activation of PPARγ and selectively modulates microglial polarization and suppresses MMP2 formation.
小胶质细胞是大脑的主要炎症细胞,可在 M1 和 M2 极化之间发生表型转换,这对炎症有相反的影响。过氧化物酶体增殖物激活受体 γ(PPARγ)是核受体家族配体诱导转录因子的成员,已知 PPARγ 调节 M2 巨噬细胞极化。先前的研究表明,天然五环三萜熊果酸(3β-羟基-urs-12-烯-28-羧酸;UA)影响小胶质细胞激活。此外,UA 增加组织抑制剂基质金属蛋白酶 1(TIMP1),同时以 PPARγ 依赖的方式大大减少基质金属蛋白酶 2(MMP2)和 MMP9 的释放。在这里,我们通过观察 UA 促进脂多糖(LPS)和干扰素γ(IFNγ)激活的 BV2 小胶质细胞从 M1 向 M2 极化的表型转变,研究了 UA 的抗炎特性。为了确定 PPARγ 是否参与潜在的分子途径,我们用 UA 和 PPARγ 抑制剂 BADGE 处理大鼠。我们还研究了 PPARγ 控制 MMP2 启动子转录的机制。体外实验表明,UA 将 LPS/IFNγ 激活的 BV2 小胶质细胞从 M1 表型转变为 M2 表型,这与神经毒性因子 MMP2 和 MMP9 的减少以及抗炎因子 TIMP1 的增加有关。同时增加 MMP2 和 MMP9 的合成,同时减少 TIMP1 的释放,表明 UA 通过激活 PPARγ 对 LPS/IFNγ 激活的 BV2 细胞具有抗炎作用。接下来,我们发现 PPARγ 通过鉴定 MMP2 启动子中的五个潜在 PPRE 中的关键过氧化物酶体增殖物反应元件(PPRE)直接影响 MMP2 转录活性。这些结果表明,UA 对神经炎症毒性具有保护抗炎作用,这是通过直接激活 PPARγ 并选择性调节小胶质细胞极化和抑制 MMP2 形成来实现的。